Abstract
The type 2 cannabinoid receptor (CB2R) is a relatively new target for drug development, as the receptor was only discovered in 1993. The CB2R is mainly expressed in tissues and organs related to the immune system. However, in pathological conditions, mostly inflammatory, a strong upregulation has been observed. Because of its expression in activated microglia, the type 2 cannabinoid receptor might play an important role in pathologies with a neuroinflammatory component. Positron emission tomography provides a sensitive non-invasive imaging technique to study and quantify receptor expression. In this review, the importance of CB2R imaging, the current status and the future possibilities for the development of CB2R PET radioligands are discussed.
Keywords: Type 2 cannabinoid receptor, PET, endocannabinoid, non-invasive imaging
Current Topics in Medicinal Chemistry
Title: Non-Invasive Imaging of the Type 2 Cannabinoid Receptor, Focus on Positron Emission Tomography
Volume: 10 Issue: 15
Author(s): Nele Evens and Guy M. Bormans
Affiliation:
Keywords: Type 2 cannabinoid receptor, PET, endocannabinoid, non-invasive imaging
Abstract: The type 2 cannabinoid receptor (CB2R) is a relatively new target for drug development, as the receptor was only discovered in 1993. The CB2R is mainly expressed in tissues and organs related to the immune system. However, in pathological conditions, mostly inflammatory, a strong upregulation has been observed. Because of its expression in activated microglia, the type 2 cannabinoid receptor might play an important role in pathologies with a neuroinflammatory component. Positron emission tomography provides a sensitive non-invasive imaging technique to study and quantify receptor expression. In this review, the importance of CB2R imaging, the current status and the future possibilities for the development of CB2R PET radioligands are discussed.
Export Options
About this article
Cite this article as:
Evens Nele and M. Bormans Guy, Non-Invasive Imaging of the Type 2 Cannabinoid Receptor, Focus on Positron Emission Tomography, Current Topics in Medicinal Chemistry 2010; 10 (15) . https://dx.doi.org/10.2174/156802610793176819
DOI https://dx.doi.org/10.2174/156802610793176819 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements